State of Wyoming’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $715K | Buy |
13,013
+7,212
| +124% | +$396K | 0.09% | 151 |
|
|
2025
Q1 | $410K | Buy |
5,801
+1,098
| +23% | +$77.6K | 0.05% | 341 |
|
|
2024
Q4 | $309K | Buy |
4,703
+3,984
| +554% | +$262K | 0.04% | 534 |
|
|
2024
Q3 | $50.5K | Sell |
719
-1,658
| -70% | -$117K | 0.01% | 1445 |
|
|
2024
Q2 | $196K | Buy |
2,377
+1,724
| +264% | +$142K | 0.03% | 572 |
|
|
2024
Q1 | $57K | Buy |
653
+319
| +96% | +$27.9K | 0.01% | 1258 |
|
|
2023
Q4 | $32.2K | Sell |
334
-3
| -0.9% | -$289 | 0.01% | 1491 |
|
|
2023
Q3 | $29.8K | Buy |
+337
| New | +$29.8K | 0.01% | 1420 |
|
|
2023
Q1 | – | Sell |
-399
| Closed | -$41.3K | – | 1601 |
|
|
2022
Q4 | $41.3K | Buy |
+399
| New | +$41.3K | 0.01% | 1127 |
|
|
2022
Q3 | – | Sell |
-648
| Closed | -$54K | – | 1560 |
|
|
2022
Q2 | $54K | Sell |
648
-5,547
| -90% | -$462K | 0.03% | 879 |
|
|
2022
Q1 | $478K | Buy |
6,195
+270
| +5% | +$20.8K | 0.24% | 28 |
|
|
2021
Q4 | $523K | Buy |
5,925
+384
| +7% | +$33.9K | 0.24% | 27 |
|
|
2021
Q3 | $428K | Sell |
5,541
-1,088
| -16% | -$84K | 0.28% | 46 |
|
|
2021
Q2 | $553K | Buy |
6,629
+6,329
| +2,110% | +$528K | 0.35% | 37 |
|
|
2021
Q1 | $23K | Buy |
+300
| New | +$23K | 0.04% | 299 |
|